Free Trial
→ Here’s How to Claim Your Stake in Elon’s Private Company, xAI (From Brownstone Research) (Ad) Buy ALAB Stock  Free ALAB Stock Alerts

Astera Labs (ALAB) Financials

Astera Labs logo
$59.41 -0.72 (-1.20%)
Closing price 04/14/2025 04:00 PM Eastern
Extended Trading
$59.68 +0.28 (+0.46%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Astera Labs

Annual Income Statements for Astera Labs

This table shows Astera Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 -58 -26 -83
Consolidated Net Income / (Loss)		 -58 -26 -83
Net Income / (Loss) Continuing Operations		 -58 -26 -83
Total Pre-Tax Income 		-58 -23 -82
Total Operating Income		 -60 -29 -116
Total Gross Profit		 59 80 303
Total Revenue		 80 116 396
Operating Revenue		 80 116 396
Total Cost of Revenue		 21 36 94
Operating Cost of Revenue		 21 36 94
Total Operating Expenses		 119 109 419
Selling, General & Admin Expense		 21 16 94
Marketing Expense		 24 20 124
Research & Development Expense		 74 73 201
Total Other Income / (Expense), net		 2.61 6.55 34
Interest & Investment Income		 2.61 6.55 34
Income Tax Expense		 0.76 3.31 1.64
Basic Earnings per Share		 ($1.71) ($0.71) ($0.64)
Weighted Average Basic Shares Outstanding		 34.17M 37.13M 131.26M
Diluted Earnings per Share		 ($1.71) ($0.71) ($0.64)
Weighted Average Diluted Shares Outstanding		 34.17M 37.13M 131.26M
Weighted Average Basic & Diluted Shares Outstanding		 - - 162.15M

Quarterly Income Statements for Astera Labs

This table shows Astera Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders		 -17 -20 -3.12 14 -93 -7.55 -7.59 25
Consolidated Net Income / (Loss)		 -17 -20 -3.12 14 -93 -7.55 -7.59 25
Net Income / (Loss) Continuing Operations		 -17 -20 -3.12 14 -93 -7.55 -7.59 25
Total Pre-Tax Income 		-17 -16 -0.25 11 -80 -14 2.02 11
Total Operating Income		 -19 -18 -1.98 9.02 -83 -24 -8.90 0.14
Total Gross Profit		 4.26 8.44 28 39 51 60 88 104
Total Revenue		 18 11 37 51 65 77 113 141
Operating Revenue		 18 11 37 51 65 77 113 141
Total Cost of Revenue		 13 2.25 8.82 11 15 17 25 37
Operating Cost of Revenue		 13 2.25 8.82 11 15 17 25 37
Total Operating Expenses		 23 26 30 30 133 84 97 104
Selling, General & Admin Expense		 3.53 3.10 3.95 5.36 24 22 23 25
Marketing Expense		 4.39 5.10 5.51 5.00 56 22 23 23
Research & Development Expense		 15 18 21 20 54 40 51 57
Total Other Income / (Expense), net		 1.60 1.56 1.72 1.67 2.55 10 11 11
Interest & Investment Income		 1.60 1.56 1.72 1.67 2.55 10 11 11
Income Tax Expense		 0.12 3.95 2.87 -3.63 13 -6.54 9.61 -14
Basic Earnings per Share		 ($0.49) ($0.55) ($0.08) $0.41 ($1.77) ($0.05) ($0.05) $1.23
Weighted Average Basic Shares Outstanding		 35.83M 36.57M 37.47M 37.13M 52.53M 155.20M 156.83M 131.26M
Diluted Earnings per Share		 ($0.49) ($0.55) ($0.08) $0.41 ($1.77) ($0.05) ($0.05) $1.23
Weighted Average Diluted Shares Outstanding		 35.83M 36.57M 37.47M 37.13M 52.53M 155.20M 156.83M 131.26M
Weighted Average Basic & Diluted Shares Outstanding		 - - - 0.00 155.70M 156.66M 158.61M 162.15M

Annual Cash Flow Statements for Astera Labs

This table details how cash moves in and out of Astera Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Change in Cash & Equivalents		 25 -31 35
Net Cash From Operating Activities		 -36 -13 137
Net Cash From Continuing Operating Activities		 -36 -13 137
Net Income / (Loss) Continuing Operations		 -58 -26 -83
Consolidated Net Income / (Loss)		 -58 -26 -83
Depreciation Expense		 0.81 1.78 3.15
Amortization Expense		 -0.53 -1.62 -8.34
Non-Cash Adjustments To Reconcile Net Income		 32 23 239
Changes in Operating Assets and Liabilities, net		 -9.97 -9.68 -13
Net Cash From Investing Activities		 -91 -18 -758
Net Cash From Continuing Investing Activities		 -91 -18 -758
Purchase of Property, Plant & Equipment		 -3.87 -2.76 -34
Purchase of Investments		 -89 -126 -931
Sale and/or Maturity of Investments		 2.00 111 209
Other Investing Activities, net		 0.00 0.00 -1.41
Net Cash From Financing Activities		 152 -0.50 656
Net Cash From Continuing Financing Activities		 152 -0.50 656
Repurchase of Common Equity		 -0.31 -1.62 -5.87
Issuance of Preferred Equity		 150 0.00 0.00
Issuance of Common Equity		 0.00 0.00 676
Other Financing Activities, net		 2.12 1.12 -15
Cash Income Taxes Paid		 0.00 2.48 7.79

Quarterly Cash Flow Statements for Astera Labs

This table details how cash moves in and out of Astera Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents		 32 -14 -56 7.38 651 -275 -295 -46
Net Cash From Operating Activities		 -3.82 -23 -0.33 14 3.65 30 64 40
Net Cash From Continuing Operating Activities		 -3.82 -23 -0.33 14 3.65 30 64 40
Net Income / (Loss) Continuing Operations		 -17 -20 -3.12 14 -93 -7.55 -7.59 25
Consolidated Net Income / (Loss)		 -17 -20 -3.12 14 -93 -7.55 -7.59 25
Depreciation Expense		 0.36 0.41 0.48 0.54 0.61 0.72 0.85 0.97
Amortization Expense		 -0.41 -0.23 -0.40 -0.59 -0.57 -1.07 -3.23 -3.47
Non-Cash Adjustments To Reconcile Net Income		 12 3.06 3.81 4.18 98 45 46 49
Changes in Operating Assets and Liabilities, net		 1.69 -6.20 -1.10 -4.06 -1.79 -7.77 27 -31
Net Cash From Investing Activities		 35 9.16 -56 -5.96 -4.25 -302 -359 -91
Net Cash From Continuing Investing Activities		 35 9.16 -56 -5.96 -4.25 -302 -359 -91
Purchase of Property, Plant & Equipment		 -0.44 -0.58 -0.74 -1.01 -3.42 1.32 -17 -15
Purchase of Investments		 -22 -4.93 -76 -23 -23 -322 -379 -206
Sale and/or Maturity of Investments		 58 15 20 18 22 19 36 131
Net Cash From Financing Activities		 0.03 -0.12 0.64 -1.06 652 -2.34 0.95 5.65
Net Cash From Continuing Financing Activities		 0.03 -0.12 0.64 -1.06 652 -2.34 0.95 5.65
Repurchase of Common Equity		 0.00 -0.09 -0.02 -1.51 -1.76 -3.05 - -1.07
Issuance of Common Equity		 0.00 - - - 672 - - 4.16
Other Financing Activities, net		 0.03 -0.03 0.66 0.45 -19 0.70 0.95 2.56

Annual Balance Sheets for Astera Labs

This table presents Astera Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024
Total Assets		 196 1,055
Total Current Assets		 186 1,013
Cash & Equivalents		 45 80
Short-Term Investments		 104 835
Accounts Receivable		 8.34 39
Inventories, net		 24 43
Prepaid Expenses		 4.06 17
Plant, Property, & Equipment, net		 4.71 36
Total Noncurrent Assets		 5.77 5.88
Other Noncurrent Operating Assets		 5.77 5.88
Total Liabilities & Shareholders' Equity		 196 1,055
Total Liabilities		 39 90
Total Current Liabilities		 35 87
Accounts Payable		 6.34 27
Accrued Expenses		 29 60
Total Noncurrent Liabilities		 3.79 3.17
Other Noncurrent Operating Liabilities		 3.79 3.17
Commitments & Contingencies		 0.00 0.00
Redeemable Noncontrolling Interest		 255 0.00
Total Equity & Noncontrolling Interests		 -98 965
Total Preferred & Common Equity		 -98 965
Total Common Equity		 -98 965
Common Stock		 27 1,173
Retained Earnings		 -125 -209
Accumulated Other Comprehensive Income / (Loss)		 0.26 0.43

Quarterly Balance Sheets for Astera Labs

This table presents Astera Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024
Total Assets		 865 916 983
Total Current Assets		 854 891 946
Cash & Equivalents		 696 421 126
Short-Term Investments		 105 410 761
Accounts Receivable		 17 22 25
Inventories, net		 30 29 24
Prepaid Expenses		 6.73 9.45 8.99
Plant, Property, & Equipment, net		 7.58 22 35
Total Noncurrent Assets		 2.88 2.45 2.34
Other Noncurrent Operating Assets		 2.88 2.45 2.34
Total Liabilities & Shareholders' Equity		 865 916 983
Total Liabilities		 56 70 93
Total Current Liabilities		 46 64 88
Accounts Payable		 11 15 19
Accrued Expenses		 34 49 69
Total Noncurrent Liabilities		 11 6.19 5.41
Other Noncurrent Operating Liabilities		 11 6.19 5.41
Commitments & Contingencies		 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 809 845 890
Total Preferred & Common Equity		 809 845 890
Total Common Equity		 809 845 890
Common Stock		 1,027 1,072 1,119
Retained Earnings		 -218 -226 -234
Accumulated Other Comprehensive Income / (Loss)		 -0.06 -0.35 4.43

Annual Metrics and Ratios for Astera Labs

This table displays calculated financial ratios and metrics derived from Astera Labs' official financial filings.

Metric 2022 2023 2024
Growth Metrics		 - - -
Revenue Growth		 0.00% 44.97% 242.24%
EBITDA Growth		 0.00% 51.03% -313.27%
EBIT Growth		 0.00% 51.00% -293.48%
NOPAT Growth		 0.00% 51.00% -293.48%
Net Income Growth		 0.00% 55.00% -217.71%
EPS Growth		 0.00% 58.48% 9.86%
Operating Cash Flow Growth		 0.00% 64.58% 1,174.83%
Free Cash Flow Firm Growth		 0.00% 0.00% -329.86%
Invested Capital Growth		 0.00% 0.00% 522.43%
Revenue Q/Q Growth		 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 1,696.44%
Profitability Metrics		 - - -
Gross Margin		 73.47% 68.94% 76.38%
EBITDA Margin		 -75.01% -25.34% -30.60%
Operating Margin		 -75.36% -25.47% -29.29%
EBIT Margin		 -75.36% -25.47% -29.29%
Profit (Net Income) Margin		 -73.05% -22.68% -21.05%
Tax Burden Percent		 101.33% 114.42% 102.01%
Interest Burden Percent		 95.66% 77.80% 70.46%
Effective Tax Rate		 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -509.01% -277.24%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -501.49% -276.83%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 475.65% 262.37%
Return on Equity (ROE)		 0.00% -33.36% -14.87%
Cash Return on Invested Capital (CROIC)		 0.00% -709.01% -421.87%
Operating Return on Assets (OROA)		 0.00% -15.03% -18.56%
Return on Assets (ROA)		 0.00% -13.38% -13.34%
Return on Common Equity (ROCE)		 0.00% 20.70% -11.49%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 26.87% -8.65%
Net Operating Profit after Tax (NOPAT)		 -42 -21 -81
NOPAT Margin		 -52.75% -17.83% -20.50%
Net Nonoperating Expense Percent (NNEP)		 0.00% -7.51% -0.41%
Return On Investment Capital (ROIC_SIMPLE)		 - 21.13% -8.42%
Cost of Revenue to Revenue		 26.53% 31.06% 23.62%
SG&A Expenses to Revenue		 25.99% 13.75% 23.79%
R&D to Revenue		 92.29% 63.39% 50.68%
Operating Expenses to Revenue		 148.83% 94.41% 105.67%
Earnings before Interest and Taxes (EBIT)		 -60 -29 -116
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -60 -29 -121
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 0.00 0.00 21.77
Price to Tangible Book Value (P/TBV)		 0.00 0.00 21.77
Price to Revenue (P/Rev)		 8.92 6.16 53.01
Price to Earnings (P/E)		 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 100.90 397.91
Enterprise Value to Revenue (EV/Rev)		 0.00 7.07 50.70
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 147.02
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00
Financial Leverage		 0.00 -0.95 -0.95
Leverage Ratio		 0.00 1.25 1.11
Compound Leverage Factor		 0.00 0.97 0.79
Debt to Total Capital		 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 162.06% 0.00%
Common Equity to Total Capital		 0.00% -62.06% 100.00%
Debt to EBITDA		 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00
Altman Z-Score		 0.00 11.13 141.30
Noncontrolling Interest Sharing Ratio		 0.00% 162.06% 22.73%
Liquidity Ratios		 - - -
Current Ratio		 0.00 5.30 11.71
Quick Ratio		 0.00 4.49 11.01
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 0.00 -29 -124
Operating Cash Flow to CapEx		 -926.88% -460.56% 399.11%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00
Efficiency Ratios		 - - -
Asset Turnover		 0.00 0.59 0.63
Accounts Receivable Turnover		 0.00 13.89 16.81
Inventory Turnover		 0.00 1.49 2.78
Fixed Asset Turnover		 0.00 24.57 19.64
Accounts Payable Turnover		 0.00 5.68 5.63
Days Sales Outstanding (DSO)		 0.00 26.27 21.71
Days Inventory Outstanding (DIO)		 0.00 244.52 131.25
Days Payable Outstanding (DPO)		 0.00 64.31 64.85
Cash Conversion Cycle (CCC)		 0.00 206.48 88.12
Capital & Investment Metrics		 - - -
Invested Capital		 0.00 8.11 50
Invested Capital Turnover		 0.00 28.55 13.52
Increase / (Decrease) in Invested Capital		 0.00 8.11 42
Enterprise Value (EV)		 0.00 819 20,094
Market Capitalization		 713 713 21,008
Book Value per Share		 $0.00 ($2.63) $6.08
Tangible Book Value per Share		 $0.00 ($2.63) $6.08
Total Capital		 0.00 157 965
Total Debt		 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00
Net Debt		 0.00 -149 -914
Capital Expenditures (CapEx)		 3.87 2.76 34
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 1.42 12
Debt-free Net Working Capital (DFNWC)		 0.00 151 926
Net Working Capital (NWC)		 0.00 151 926
Net Nonoperating Expense (NNE)		 16 5.61 2.17
Net Nonoperating Obligations (NNO)		 0.00 -149 -914
Total Depreciation and Amortization (D&A)		 0.28 0.16 -5.19
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 1.22% 3.06%
Debt-free Net Working Capital to Revenue		 0.00% 130.17% 233.78%
Net Working Capital to Revenue		 0.00% 130.17% 233.78%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.64)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 131.26M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.64)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 131.26M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 162.15M
Normalized Net Operating Profit after Tax (NOPAT)		 -42 -21 -81
Normalized NOPAT Margin		 -52.75% -17.83% -20.50%
Pre Tax Income Margin		 -72.09% -19.82% -20.64%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -0.54% -6.16% -7.03%

Quarterly Metrics and Ratios for Astera Labs

This table displays calculated financial ratios and metrics derived from Astera Labs' official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics		 - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 269.44% 619.03% 206.23% 179.32%
EBITDA Growth		 0.00% 0.00% 0.00% 0.00% -336.85% -41.67% -494.20% -126.24%
EBIT Growth		 0.00% 0.00% 0.00% 0.00% -338.35% -38.23% -349.97% -98.40%
NOPAT Growth		 0.00% 0.00% 0.00% 0.00% -338.35% -38.23% 2,521.10% -97.25%
Net Income Growth		 0.00% 0.00% 0.00% 0.00% -432.80% 62.28% -143.05% 72.52%
EPS Growth		 0.00% 0.00% 0.00% 0.00% -261.22% 90.91% 37.50% 200.00%
Operating Cash Flow Growth		 0.00% 0.00% 0.00% 0.00% 195.63% 229.84% 19,114.37% 175.73%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 522.43%
Revenue Q/Q Growth		 0.00% -39.49% 245.51% 36.79% 0.00% 17.76% 47.15% 24.77%
EBITDA Q/Q Growth		 0.00% 8.14% 89.11% 572.87% 0.00% 70.21% 54.34% 79.12%
EBIT Q/Q Growth		 0.00% 6.94% 88.78% 556.25% 0.00% 70.65% 63.46% 101.62%
NOPAT Q/Q Growth		 0.00% 6.94% 88.78% 973.08% 0.00% 70.65% 296.60% -99.01%
Net Income Q/Q Growth		 0.00% -14.61% 84.38% 558.55% 0.00% 91.89% -0.62% 425.47%
EPS Q/Q Growth		 0.00% -12.24% 85.45% 612.50% 0.00% 97.18% 0.00% 2,560.00%
Operating Cash Flow Q/Q Growth		 0.00% -501.26% 98.55% 4,411.08% 0.00% 716.35% 113.02% -37.48%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 52.19% 198.07% -237.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 92.84% -80.28% 1,696.44%
Profitability Metrics		 - - - - - - - -
Gross Margin		 24.11% 78.96% 76.11% 77.26% 77.42% 77.88% 77.71% 74.03%
EBITDA Margin		 -107.46% -163.14% -5.14% 17.77% -127.06% -32.14% -9.97% -1.67%
Operating Margin		 -107.15% -164.79% -5.35% 17.86% -127.14% -31.68% -7.87% 0.10%
EBIT Margin		 -107.15% -164.79% -5.35% 17.86% -127.14% -31.68% -7.87% 0.10%
Profit (Net Income) Margin		 -98.81% -187.16% -8.46% 28.36% -142.50% -9.82% -6.71% 17.52%
Tax Burden Percent		 100.71% 124.57% 1,234.78% 133.95% 115.65% 53.58% -376.64% 230.92%
Interest Burden Percent		 91.57% 91.17% 12.80% 118.56% 96.92% 57.84% -22.66% 7,431.94%
Effective Tax Rate		 0.00% 0.00% 0.00% -33.95% 0.00% 0.00% 476.64% -130.92%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 341.39% 0.00% 0.00% 0.00% 3.19%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 339.89% 0.00% 0.00% 0.00% -1.40%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% -322.37% 0.00% 0.00% 0.00% 1.32%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 19.02% 0.00% 0.00% 0.00% 4.51%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% -354.50% 0.00% 0.00% 0.00% -421.87%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 10.53% 0.00% 0.00% 0.00% 0.06%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 16.73% 0.00% 0.00% 0.00% 11.10%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% -11.80% 0.00% 0.00% 0.00% 3.49%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -13 -12 -1.38 12 -58 -17 34 0.33
NOPAT Margin		 -75.01% -115.35% -3.75% 23.92% -89.00% -22.18% 29.63% 0.24%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 1.50% -8.71% 2.29% -9.27% 4.58%
Return On Investment Capital (ROIC_SIMPLE)		 - - - -12.37% - - - 0.03%
Cost of Revenue to Revenue		 75.89% 21.04% 23.89% 22.74% 22.58% 22.12% 22.29% 25.97%
SG&A Expenses to Revenue		 19.96% 28.96% 10.69% 10.60% 37.42% 28.67% 20.22% 17.69%
R&D to Revenue		 86.43% 167.10% 55.85% 38.91% 82.07% 52.17% 44.80% 40.06%
Operating Expenses to Revenue		 131.26% 243.75% 81.46% 59.40% 204.55% 109.57% 85.57% 73.92%
Earnings before Interest and Taxes (EBIT)		 -19 -18 -1.98 9.02 -83 -24 -8.90 0.14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -19 -17 -1.90 8.98 -83 -25 -11 -2.36
Valuation Ratios		 - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 1.82 11.15 9.23 21.77
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 1.82 11.15 9.23 21.77
Price to Revenue (P/Rev)		 0.00 0.00 0.00 6.16 0.00 0.00 0.00 53.01
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 100.90 90.30 602.55 2,604.21 397.91
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 7.07 0.00 0.00 0.00 50.70
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 147.02
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 0.00 0.00 -0.95 -0.99 -0.98 -1.00 -0.95
Leverage Ratio		 0.00 0.00 0.00 1.25 1.07 1.08 1.11 1.11
Compound Leverage Factor		 0.00 0.00 0.00 1.48 1.04 0.63 -0.25 82.83
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 162.06% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 0.00% 0.00% -62.06% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 0.00 0.00 11.77 16.16 81.10 53.38 141.66
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 162.06% 0.00% 0.00% 0.00% 22.73%
Liquidity Ratios		 - - - - - - - -
Current Ratio		 0.00 0.00 0.00 5.30 18.74 13.91 10.74 11.71
Quick Ratio		 0.00 0.00 0.00 4.49 17.95 13.32 10.36 11.01
Cash Flow Metrics		 - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 0.00 0.00 -65 -31 31 -42
Operating Cash Flow to CapEx		 -869.93% -3,993.39% -45.38% 1,424.23% 106.66% 0.00% 380.36% 257.01%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.59 0.00 0.00 0.00 0.63
Accounts Receivable Turnover		 0.00 0.00 0.00 13.89 0.00 0.00 0.00 16.81
Inventory Turnover		 0.00 0.00 0.00 1.49 0.00 0.00 0.00 2.78
Fixed Asset Turnover		 0.00 0.00 0.00 24.57 0.00 0.00 0.00 19.64
Accounts Payable Turnover		 0.00 0.00 0.00 5.68 0.00 0.00 0.00 5.63
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 26.27 0.00 0.00 0.00 21.71
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 244.52 0.00 0.00 0.00 131.25
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 64.31 0.00 0.00 0.00 64.85
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 206.48 0.00 0.00 0.00 88.12
Capital & Investment Metrics		 - - - - - - - -
Invested Capital		 0.00 0.00 0.00 8.11 7.39 14 2.81 50
Invested Capital Turnover		 0.00 0.00 0.00 14.27 0.00 0.00 0.00 13.52
Increase / (Decrease) in Invested Capital		 0.00 0.00 0.00 0.00 7.39 14 2.81 42
Enterprise Value (EV)		 0.00 0.00 0.00 819 668 8,590 7,320 20,094
Market Capitalization		 713 713 713 713 1,469 9,421 8,207 21,008
Book Value per Share		 $0.00 $0.00 $0.00 ($2.63) $15.40 $5.43 $5.68 $6.08
Tangible Book Value per Share		 $0.00 $0.00 $0.00 ($2.63) $15.40 $5.43 $5.68 $6.08
Total Capital		 0.00 0.00 0.00 157 809 845 890 965
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 0.00 0.00 0.00 -149 -801 -831 -887 -914
Capital Expenditures (CapEx)		 0.44 0.58 0.74 1.01 3.42 -1.32 17 15
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 0.00 0.00 1.42 7.46 -3.82 -29 12
Debt-free Net Working Capital (DFNWC)		 0.00 0.00 0.00 151 809 827 858 926
Net Working Capital (NWC)		 0.00 0.00 0.00 151 809 827 858 926
Net Nonoperating Expense (NNE)		 4.21 7.67 1.74 -2.24 35 -9.50 41 -24
Net Nonoperating Obligations (NNO)		 0.00 0.00 0.00 -149 -801 -831 -887 -914
Total Depreciation and Amortization (D&A)		 -0.05 0.18 0.08 -0.05 0.05 -0.35 -2.38 -2.50
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 1.22% 0.00% 0.00% 0.00% 3.06%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 130.17% 0.00% 0.00% 0.00% 233.78%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 130.17% 0.00% 0.00% 0.00% 233.78%
Earnings Adjustments		 - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.41 ($1.77) ($0.05) ($0.05) $1.23
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 37.13M 52.53M 155.20M 156.83M 131.26M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.41 ($1.77) ($0.05) ($0.05) $1.23
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 37.13M 52.53M 155.20M 156.83M 131.26M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 155.70M 156.66M 158.61M 162.15M
Normalized Net Operating Profit after Tax (NOPAT)		 -13 -12 -1.38 6.31 -58 -17 -6.23 0.10
Normalized NOPAT Margin		 -75.01% -115.35% -3.75% 12.50% -89.00% -22.18% -5.51% 0.07%
Pre Tax Income Margin		 -98.11% -150.24% -0.69% 21.17% -123.22% -18.33% 1.78% 7.58%
Debt Service Ratios		 - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% -6.16% 0.00% 0.00% 0.00% -7.03%

Frequently Asked Questions About Astera Labs' Financials

When does Astera Labs's fiscal year end?

According to the most recent income statement we have on file, Astera Labs' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Astera Labs' net income changed over the last 2 years?

Astera Labs' net income appears to be on an upward trend, with a most recent value of -$83.42 million in 2024, rising from -$58.35 million in 2022. The previous period was -$26.26 million in 2023.

What is Astera Labs's operating income?
Astera Labs's total operating income in 2024 was -$116.07 million, based on the following breakdown:
  • Total Gross Profit: $302.70 million
  • Total Operating Expenses: $418.77 million
How has Astera Labs revenue changed over the last 2 years?

Over the last 2 years, Astera Labs' total revenue changed from $79.87 million in 2022 to $396.29 million in 2024, a change of 396.2%.

How much debt does Astera Labs have?

Astera Labs' total liabilities were at $89.71 million at the end of 2024, a 130.8% increase from 2023, and a 130.8% increase since 2023.

How much cash does Astera Labs have?

In the past 1 years, Astera Labs' cash and equivalents has ranged from $45.10 million in 2023 to $79.55 million in 2024, and is currently $79.55 million as of their latest financial filing in 2024.

How has Astera Labs' book value per share changed over the last 2 years?

Over the last 2 years, Astera Labs' book value per share changed from 0.00 in 2022 to 6.08 in 2024, a change of 608.3%.

Remove Ads

Related Companies

This page (NASDAQ:ALAB) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...
InvestorPlace | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
DOGE tax surprise
Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...
Altimetry | Sponsored
Amazon Shocker
Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...
Stansberry Research | Sponsored
Caught on Camera: Elon Musk’s “Area 51”
You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...
Brownstone Research | Sponsored
Three new patents reveal Elon and Trump’s secret “Project America”
Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...
Timothy Sykes | Sponsored